Literature DB >> 22244180

Video-assisted thoracoscopic surgery for esophageal cancer attenuates postoperative systemic responses and pulmonary complications.

Hironori Tsujimoto1, Risa Takahata, Shinsuke Nomura, Yoshihisa Yaguchi, Isao Kumano, Yusuke Matsumoto, Kazumichi Yoshida, Hiroyuki Horiguchi, Shuichi Hiraki, Satoshi Ono, Junji Yamamoto, Kazuo Hase.   

Abstract

BACKGROUND: Less invasive operations such as laparoscopic surgery have been developed for treating gastrointestinal malignancies. However, the advantages of video-assisted thoracoscopic surgery for esophageal cancer (VATS-e) with regard to postoperative morbidity and mortality remains controversial.
METHODS: We investigated the postoperative clinical course of patients who underwent esophagectomy for esophageal cancer in terms of systemic inflammatory response syndrome (SIRS) induced by VATS-e (VATS-e group) or conventional open surgery (OS group) combined with laparoscopic gastric tube reconstruction.
RESULTS: Compared with the OS group (n = 27), the VATS-e group (n = 22) had a greater thoracic operation time (VATS-e versus OS, 181 ± 56 vs 143 ± 45 minutes, respectively), and lesser duration of stay in the intensive care unit (17 ± 2 vs 32 ± 21 hours, respectively). The VATS-e group also had a lesser SIRS duration (1.5 vs 4.3 days), a lesser incidence of SIRS, a lesser number of positive SIRS criteria, and lesser serum interleukin-6 levels immediately after operation and on postoperative day (POD) 1. The heart rate in the VATS-e group was less than that in the OS group on POD 3. The respiratory rate in the VATS-e group was significantly less than that in the OS group on PODs 3, 5, and 7. Although no difference was observed in the frequencies of postoperative complications between the 2 groups, the VATS-e group had less postoperative pneumonia.
CONCLUSION: VATS-e attenuates postoperative SIRS, and is therefore a potentially less invasive operative procedure.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22244180     DOI: 10.1016/j.surg.2011.12.006

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  34 in total

1.  Muscle sparing thoracotomy for esophageal cancer: a comparison with posterolateral thoracotomy.

Authors:  Kazushi Miyata; Masahide Fukaya; Keita Itatsu; Tetsuya Abe; Masato Nagino
Journal:  Surg Today       Date:  2015-08-27       Impact factor: 2.549

2.  The feasibility of laparoscopic extended pelvic surgery for rectal cancer.

Authors:  Hayato Nakamura; Keisuke Uehara; Atsuki Arimoto; Takehiro Kato; Tomoki Ebata; Masato Nagino
Journal:  Surg Today       Date:  2015-10-22       Impact factor: 2.549

Review 3.  Laparoscopic and robot-assisted laparoscopic digestive surgery: Present and future directions.

Authors:  Juan C Rodríguez-Sanjuán; Marcos Gómez-Ruiz; Soledad Trugeda-Carrera; Carlos Manuel-Palazuelos; Antonio López-Useros; Manuel Gómez-Fleitas
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

Review 4.  Strategies to reduce pulmonary complications after esophagectomy.

Authors:  Teus J Weijs; Jelle P Ruurda; Grard A P Nieuwenhuijzen; Richard van Hillegersberg; Misha D P Luyer
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

5.  Minimally invasive esophagectomy-left neck anastomosis.

Authors:  Huaguang Pan; Xu Hu; Zaicheng Yu; Renquan Zhang; Wei Ge; Jianjun Ge
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

6.  Nutritional benefit of laparoscopic jejunostomy during neoadjuvant chemotherapy for obstructing esophageal cancer.

Authors:  Ken Nagata; Hironori Tsujimoto; Hiromi Nagata; Manabu Harada; Nozomi Ito; Shinsuke Nomura; Hiroyuki Horiguchi; Shuichi Hiraki; Suefumi Aosasa; Kazuo Hase; Hideki Ueno
Journal:  Mol Clin Oncol       Date:  2019-10-16

7.  C-Reactive Protein Indicates Early Stage of Postoperative Infectious Complications in Patients Following Minimally Invasive Esophagectomy.

Authors:  Yuichiro Miki; Takahiro Toyokawa; Naoshi Kubo; Tatsuro Tamura; Katsunobu Sakurai; Hiroaki Tanaka; Kazuya Muguruma; Masakazu Yashiro; Kosei Hirakawa; Masaichi Ohira
Journal:  World J Surg       Date:  2017-03       Impact factor: 3.352

8.  Efficacy of artificial pneumothorax under two-lung ventilation in video-assisted thoracoscopic surgery for esophageal cancer.

Authors:  Shinsuke Nomura; Hironori Tsujimoto; Yusuke Ishibashi; Seiichiro Fujishima; Keita Kouzu; Manabu Harada; Nozomi Ito; Yoshihisa Yaguchi; Daizoh Saitoh; Takehiko Ikeda; Kazuo Hase; Yoji Kishi; Hideki Ueno
Journal:  Surg Endosc       Date:  2020-01-13       Impact factor: 4.584

9.  Margin Positivity in Resectable Esophageal Cancer: Are there Modifiable Risk Factors?

Authors:  Cary Jo R Schlick; Rhami Khorfan; David D Odell; Ryan P Merkow; David J Bentrem
Journal:  Ann Surg Oncol       Date:  2020-01-13       Impact factor: 5.344

10.  Postoperative pneumonia causes the loss of skeletal muscle volume and poor prognosis in patients undergoing esophagectomy for esophageal cancer.

Authors:  Seiichiro Fujishima; Hironori Tsujimoto; Ken Nagata; Hidekazu Sugasawa; Shinsuke Nomura; Nozomi Ito; Manabu Harada; Takao Sugihara; Yusuke Ishibashi; Keita Kouzu; Hiroshi Shinmoto; Yoji Kishi; Hideki Ueno
Journal:  Gen Thorac Cardiovasc Surg       Date:  2020-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.